Camp4 Therapeutics (CAMP) Revenue (2023 - 2026)

Camp4 Therapeutics has reported Revenue for 4 years, with the latest figure at $1.3 million in Q1 2026.

• Quarterly Revenue rose 50.82% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 160.53% YoY) and the FY2025 annual result came in at $3.5 million, up 436.5% from the prior year.
• Revenue rose to $1.3 million in Q1 2026 per CAMP's latest filing, from $348000.0 in the prior quarter.
• Over five years, Revenue peaked at $1.5 million in Q2 2025 and troughed at $348000.0 in Q4 2025.
• A 4-year average of $827714.3 and a median of $795000.0 in 2025 frame the typical range for Revenue.
• The sharpest annual moves came in 2025 and 2026: Revenue slumped 46.63% in 2025, then surged 50.82% in 2026.
• Over 4 years, Revenue stood at $350000.0 in 2023, then jumped by 86.29% to $652000.0 in 2024, then plunged by 46.63% to $348000.0 in 2025, then soared by 271.84% to $1.3 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.3 million, $348000.0, and $795000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.